Different expression of androgen receptor coactivators in human prostate

By Fujimoto N.   Mizokami A.   Harada S.   Matsumoto T.  

Urology, Vol. 58, Iss. 2, 2001-08 ,pp. : 289-294

Elsevier

Access to resources Recommend Favorite

Comparison of proliferating cell nuclear antigen immunostaining in lymph node metastases and primary prostate adenocarcinoma after neoadjuvant androgen deprivation therapy

By Minardi Daniele   Galosi Andrea   Giannulis Ioannis   Montironi Rodolfo   Polito Mario   Muzzonigro Giovanni  

Scandinavian Journal of Urology and Nephrology, Vol. 38, Iss. 1, 2004-02 ,pp. : 19-25

Informa Healthcare

Access to resources Recommend Favorite

Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate

By Brufsky A.   Fontaine-Rothe P.   Berlane K.   Rieker P.   Jiroutek M.   Kaplan I.   Kaufman D.   Kantoff P.  

Urology, Vol. 49, Iss. 6, 1997-06 ,pp. : 913-920

Elsevier

Access to resources Recommend Favorite

Dramatic rise in prostate-specific antigen after androgen replacement in a hypogonadal man with occult adenocarcinoma of the prostate

By Curran M.J.   Bihrle W.  

Urology, Vol. 53, Iss. 2, 1999-02 ,pp. : 423-424

Elsevier

Access to resources Recommend Favorite

Effects of hepatocyte growth factor on E-cadherin-mediated cell-cell adhesion in DU145 prostate cancer cells

By Miura H.   Nishimura K.   Tsujimura A.   Matsumiya K.   Matsumoto K.   Nakamura T.   Okuyama A.  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 1064-1069

Elsevier

Access to resources Recommend Favorite